Michael Jacobsen

Direttore Finanziario/CFO presso OMEROS CORPORATION

Patrimonio netto: 42 840 $ in data 30/04/2024

65 anni

Health Technology

Consumer Services

Posizioni attive di Michael Jacobsen

Società	Posizione	Inizio	Fine
OMEROS CORPORATION	Comptroller/Controller/Auditor	01/10/2013	-
	Direttore Finanziario/CFO	01/08/2013	-
	Treasurer	01/10/2013	-

Società	Posizione	Inizio	Fine
SAREPTA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	08/09/2011	-
	Direttore Finanziario/CFO	09/09/2011	15/11/2011
	Corporate Officer/Principal	08/09/2011	08/09/2011
	Segretario Aziendale	07/09/2011	22/04/2013
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Direttore operativo	01/04/2007	01/08/2011
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Comptroller/Controller/Auditor	-	-
	Direttore Finanziario/CFO	-	-

Idaho State University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Comptroller/Controller/Auditor	3
Director of Finance/CFO	3
Corporate Officer/Principal	1

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
SAREPTA THERAPEUTICS, INC.	Health Technology
OMEROS CORPORATION	Health Technology

Aziende private	2
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology

Aziende private

Health Technology